Log on / register
Feedback | Support | My details
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.
Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H, van de Vijver MJ
Breast Cancer Res 2007, 9:R65
[Full text] [PubMed] [Related articles] [F1000 Medicine] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.
Weigelt B, Bissell MJ
Semin Cancer Biol 2008 Oct, 18:311-21
[PubMed Central] [PubMed] [Related articles]

2.
Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ
PLoS One 2009, 4:e4710
[PubMed Central] [PubMed] [Related articles]

3.
CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer.
Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerød A, Han W, Noh DY, Huntsman DG, Jeffrey SS, Børresen-Dale AL, Pollack JR
Mol Oncol 2008 Dec, 2:327-39
[PubMed Central] [PubMed] [Related articles]

4.
Treatment options for breast cancer resistant to anthracycline and taxane.
Moreno-Aspitia A, Perez EA
Mayo Clin Proc 2009 Jun, 84:533-45
[PubMed Central] [PubMed] [Related articles]

5.
Immunomodulation of Breast Cancer via Tumor Antigen Specific Th1.
Disis ML, Park KH
Cancer Res Treat 2009 Sep, 41:117-21
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 11 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.